Inventor · disambiguated record
Bart Klein
Also filed as: KLEIN BART
9 granted patents·6 pending applications·57 citations·filing 2014–2024
87Inventor score
Top patents by PatentIndex Score
15 records- 0193US11851656B2Chemically modified single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2021·Granted Dec 26, 2023·6 cites·40 claims
- 0293US10941402B2Chemically modified single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2017·Granted Mar 9, 2021·16 cites·22 claims
- 0393US10676737B2Targeted RNA editingPROQR THERAPEUTICS II BV·Filed 2015·Granted Jun 9, 2020·12 cites·31 claims
- 0492US11781134B2Targeted RNA editingPROQR THERAPEUTICS II BV·Filed 2020·Granted Oct 10, 2023·3 cites·19 claims
- 0591US12203072B2Chemically modified single-stranded rna-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2023·Granted Jan 21, 2025·1 cites·29 claims
- 0691US12018257B2Single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2023·Granted Jun 25, 2024·2 cites·13 claims
- 0790US11649454B2Single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2021·Granted May 16, 2023·4 cites·41 claims
- 0888US10988763B2Single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2017·Granted Apr 27, 2021·13 cites·20 claims
- 0985US2025223593A1Chemically modified single-stranded rna-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2024·Application pending·0 cites
- 1078US2024141336A1Targeted rna editingPROQR THERAPEUTICS II BV·Filed 2023·Application pending·0 cites
- 1168US2024229030A9Nucleic acid molecules for pseudouridylationUNIV ROCHESTER·Filed 2023·Application pending·0 cites
- 1264US2025154504A1Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemiaPROQR THERAPEUTICS II BV·Filed 2023·Application pending·0 cites
- 1362US11866702B2Nucleic acid molecules for pseudouridylationUNIV ROCHESTER·Filed 2019·Granted Jan 9, 2024·0 cites·24 claims
- 1453US2016228339A1Oral hygiene compositionsGLYMUR B V·Filed 2014·Application pending·0 cites
- 1551US2022340900A1Chemically modified oligonucleotides for rna editingPROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bart Klein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →